Amali

What Amali does

Amali is a Madrid-based, privately held company focused on the low-FODMAP dietary approach, a regimen commonly used to manage irritable bowel syndrome (IBS) and related digestive sensitivities. The company's website domain (amalifodmap.com) and its self-description — positioning itself as helping consumers "discover, understand and incorporate" items "in a natural and happy way" — indicate a niche consumer-health venture targeting individuals seeking guidance on FODMAP-appropriate foods. Founded in 2014, the company operates with a team of 1-10 employees, consistent with a micro-stage, founder-led operation rather than a scaled enterprise.

The available source material provides no detail on Amali's specific product surface, technology stack, or platform architecture. The live website returned only a loading/verification page during data collection, and the source data contains no documented proprietary technology, mobile application, API surface, integrations, or patents. The core-technology field is blank, and no AI/ML capabilities, data assets, or compliance certifications are documented. Consequently, the company's underlying product mechanism — whether editorial content, e-commerce, subscription, software, or a hybrid — cannot be characterized from the available evidence.

No revenue model, pricing structure, distribution channel, or go-to-market detail is disclosed in the input. There is no public information on funding rounds, investor backing, named customers, customer segments, marketing channels, or partnership arrangements. With headcount capped at 1-10 employees and no disclosed revenue, Amali appears to be a micro-stage consumer-health entity whose commercial model, traction, and unit economics cannot be assessed from the data provided.

Name

Amali

Website

https://amalifodmap.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Amali is a Madrid-based micro-company focused on the low-FODMAP diet, serving individuals seeking dietary guidance for digestive health. Founded in 2014, it operates a niche consumer platform aimed at helping users discover, understand, and adopt FODMAP-appropriate foods.

Ownership category

akta.pro rank

Product category

Digestive Health & Nutrition Services

NAICS

Diet and Weight Reducing Centers (812191)

akta.pro primary industry

Gut Health & Digestive Nutrition (IBS, GERD, Elimination Diets) (HSADAFAH)

Keywords

• Low FODMAP diet
• Digestive health services
• IBS dietary guidance
• Nutrition coaching
• Gut health consulting

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Services

Core offering

Amali helps individuals discover, understand, and incorporate low FODMAP-compatible foods into their lives in a natural and happy way, addressing digestive-health and dietary management needs. The service is delivered through its dedicated FODMAP-focused website, targeting consumers seeking guidance on FODMAP-related eating.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Emerging players

• Viome: Gut-microbiome testing and personalized nutrition recommendations company. Comparable through the gut-health / personalized-nutrition lens, though anchored on lab testing rather than dietary coaching.
• Bowelle: Gut-health and IBS symptom tracking app. Comparable as a digital gut-health tool for IBS sufferers, with narrower overlap and similar consumer use case to Amali.
• Zoe: Personalized nutrition company built on gut-microbiome and metabolic science. Comparable as a gut-health-led personalized nutrition platform targeting consumer wellness, though broader and more science-marketing driven than Amali's elimination-diet focus.

Direct peers

• Cara Care: Digital gut-health platform offering IBS and digestive-condition tracking plus personalized nutrition guidance. Directly comparable as a digital-first gut-health / IBS coaching product serving similar end users.
• Monash University FODMAP Diet App: The originator of the low-FODMAP dietary framework with a consumer tracking app. Directly comparable to Amali because it serves the same IBS / elimination-diet audience with FODMAP-specific guidance, though at vastly greater scale and clinical authority.
• Fodmap Helper: Dedicated FODMAP tracking app helping users identify low- and high-FODMAP foods. Directly comparable because it targets the same low-FODMAP elimination-diet user with similar functional benefits.

Broad incumbents

• Noom: Large-scale consumer coaching platform for nutrition, behavior change, and weight management. Comparable as a structured nutrition-coaching product serving paying consumer audiences, though broader and weight-loss-focused rather than gut-health-specific.
• MyFitnessPal: Mass-market food and nutrition tracking app. Comparable as a general-purpose nutrition-tracking consumer tool, though far broader and not specialized for FODMAP or IBS.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

• Facebookfacebook.com/AmaliFodmap
• LinkedInlinkedin.com/company/amali

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amali